Philip A. Fain - 07 Dec 2023 Form 4 Insider Report for ULTRALIFE CORP (ULBI)

Reporting relationship: CFO and Treasurer
Issuer ticker: ULBI
Reported as of: 07 Dec 2023
Net transaction value: +$125,771
SEC form: 4
Accepted by SEC: 11 Dec 2023, 16:04:02 UTC
Prior SEC filing: 23 May 2023
Next SEC filing: 19 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Philip Fain

Key filing fact

Philip A. Fain filed Form 4 for ULTRALIFE CORP (ULBI) on 11 Dec 2023.

Key facts

This page summarizes Philip A. Fain's Form 4 filing for ULTRALIFE CORP (ULBI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Dec 2023, 16:04.

Change

Previous filing in this sequence was filed on 23 May 2023.
Current net transaction value: +$125,771.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ULBI transaction Derivative

Stock Options for ULBI Common Stock; $.10 par Value

Award

Transaction value: $125,771
Shares: +18,400
Change %: +15%
Price: $6.84
Shares after: 143,400
Date: 07 Dec 2023
Ownership: Direct
Underlying class: Stock Options for ULBI Common Stock; $.10 par Value
Underlying amount: 18,400
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On December 7, 2023 Ultralife Corporation's Board of Directors awarded 18,400 stock options to Philip A. Fain under Ultralife's 2014 Long-Term Incentive Plan as Amended. These options vest as follows: 6,134 options vest on December 7, 2024; 6,133 options vest on December 7, 2025 and 6,133 options vest on December 7, 2026. The price reported is the volume weighted average price (VWAP) for Ultralife Common Stock on December 7, 2023, the date of award.